Witoshkin Walter W 5
5 · Echo Therapeutics, Inc. · Filed Apr 30, 2010
Insider Transaction Report
Form 5
Witoshkin Walter W
Director
Transactions
- Award
Common stock
2009-08-18+25,000→ 444,521 total - Award
Non-qualified stock options
2009-02-20$0.55/sh+50,000$27,500→ 444,521 totalExercise: $0.55Exp: 2019-02-20→ Common stock (50,000 underlying) - Award
Common stock
2009-06-15+50,000→ 444,521 total
Footnotes (3)
- [F1]One third of the options vested on February 20, 2010, one-third of the options will vest on February 20, 2011, and the remainder will vest on February 20, 2012.
- [F2]Includes 308,334 shares that may be acquired by Mr. Witoshkin within 60 days upon the exercise of stock options.
- [F3]The restricted shares shall vest upon the first to occur of (i) FDA approval of the Companys Symphony tCGM System; or (ii) the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for liquid proceeds, which was defined as (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities.